Stock Rich List
#1765 on the rich list of 14,452 insiders

Joseph P. Lyssikatos

CHIEF SCIENTIFIC OFFICER at Enliven Therapeutics. Based in Boulder, Colorado.

$81.3M
in disclosed stock, +$2.7M (+3.39%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
1765th of 14,452
Companies held
1
Largest holding
ELVN, 100.0% of total
Latest SEC filing
Feb 12, 2026

What the $81.3M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Enliven Therapeutics ELVN
Common Stock
Indirectly (see filing footnote)992,658$46.41$46.1M56.7%Form 4, May 1, 2025
Enliven Therapeutics ELVN
Common Stock
Through Lyssikatos Revocable Trust740,188$46.41$34.4M42.3%Form 4, Feb 12, 2026
Enliven Therapeutics ELVN
Common Stock
Directly18,750$46.41$870K1.1%Form 4, Feb 12, 2026

Share counts are the amounts Joseph P. Lyssikatos reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Feb 6, 2026SoldELVN5,000$29.04$145KView
Jan 20, 2026SoldELVN14,509$26.90$390KView
Jan 20, 2026SoldELVN5,491$26.37$145KView
Jan 9, 2026SoldELVN41,198$24.90$1.0MView
Jan 9, 2026SoldELVN50,000$29.13$1.5MView
Jan 8, 2026SoldELVN7,500$20.13$151KView
Jan 8, 2026SoldELVN33,802$24.92$842KView
Dec 19, 2025SoldELVN5,000$16.84$84KView
Nov 19, 2025SoldELVN12,008$22.30$268KView
Nov 19, 2025SoldELVN492$23.09$11KView
Oct 20, 2025SoldELVN12,500$22.08$276KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
1762Shawn Henry
CHIEF SECURITY OFFICER, CrowdStrike Holdings. New York, NY
$81.6M+$2.1M (+2.66%)
1763Nelson Knight
President Real Estate & Invest, Apple Hospitality REIT. Richmond, VA
$81.5M−$2.1M (−2.55%)
1764Michael F. Mahoney
Chairman, President & CEO, Boston Scientific. Marlborough, MA
$81.4M−$1.2M (−1.50%)
1765Joseph P. Lyssikatos
CHIEF SCIENTIFIC OFFICER, Enliven Therapeutics. Boulder, CO
$81.3M+$2.7M (+3.39%)
1766Lloyd D. Frink
Co -Exec. Chairman & President, Zillow Group. Seattle, WA
$81.3M−$2.6M (−3.09%)
1767Michael Eugene McBride
Chief Revenue Officer, GitLab. Not Applicable, DE
$81.2M−$1.5M (−1.84%)
1768Scott Staples
Chief Executive Officer, First Advantage. Atlanta, GA
$81.2M−$1.4M (−1.72%)

Other Enliven Therapeutics insiders

All ELVN insiders

Questions

How much stock does Joseph P. Lyssikatos own?

Joseph P. Lyssikatos holds $81,291,570 in listed stock based on SEC filings and current prices, mostly Enliven Therapeutics (ELVN). That ranks 1765th on the Stock Rich List.

Is this Joseph P. Lyssikatos's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Joseph P. Lyssikatos last buy or sell stock?

The most recent open-market trade on file is a sale of 5,000 ELVN shares on Feb 6, 2026 at $29.04.